Stryker Corporation logo
Stryker Corporation (SYK)
Compare

Stryker Corporation (SYK) PEG Ratio: 5.16

Is Stryker Corporation’s PEG ratio high or low?

Stryker Corporation's PEG ratio of 5.16 is 96% above its 4-year average of 2.63, near the high end of its 4-year range (1.06–5.16).

SYK PEG Ratio Chart

SYK PEG Ratio
5.16+386.79% 1Y
Zoom

SYK Average PEG Ratio Chart

SYK Current vs Average PEG Ratio Chart

SYK PEG Ratio Metrics

PEG RATIO

5.16

PEG RATIO AVG TTM

N/A

PEG RATIO AVG 3Y

2.81

PEG RATIO AVG 5Y

2.63

PEG RATIO AVG 10Y

1.79

PEG RATIO AVG 15Y

1.70

PEG RATIO AVG 20Y

1.19

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

+83.63%

CURRENT VS 5Y AVG

+96.20%

CURRENT VS 10Y AVG

+188.73%

CURRENT VS 15Y AVG

+203.13%

CURRENT VS 20Y AVG

+332.70%

SYK Competitors' PEG Ratio

NAMEMARKET CAPPEG RATIOTTM3Y5Y
Stryker Corporation (SYK)$119.06B5.16N/A2.812.63
Bristol-Myers Squibb Company (BMY)vs ›$114.38B1.680.240.240.18
Vertex Pharmaceuticals Incorporated (VRTX)vs ›$113.82B3.272.581.901.47
CVS Health Corporation (CVS)vs ›$127.54BN/A0.131.201.16
Danaher Corporation (DHR)vs ›$128.72B87.571.211.111.91
Medtronic plc (MDT)vs ›$104.05B6.733.743.742.73
Intuitive Surgical, Inc. (ISRG)vs ›$148.26B3.173.022.602.27
Pfizer Inc. (PFE)vs ›$148.76BN/A0.070.130.16
HCA Healthcare, Inc. (HCA)vs ›$88.05B0.560.710.710.86
Elevance Health Inc. (ELV)vs ›$86.74B2.566.994.823.75

Growth-Adjusted Valuation

PEG Ratio

5.16

P/E Ratio

36.0

Stryker Corporation PEG Ratio Formula & Definition

PEG Ratio = PE Ratio / Earnings Growth Rate

The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Stryker Corporation PEG Ratio FAQ

What is the PEG ratio for Stryker Corporation (SYK)?
The PEG ratio for SYK stock is 5.16.
Is Stryker Corporation's PEG ratio high or low?
Stryker Corporation's PEG ratio of 5.16 is 96% above its 4-year average of 2.63, near the high end of its 4-year range (1.06–5.16).
What is the 3Y average PEG ratio for Stryker Corporation (SYK)?
The 3Y average PEG ratio for SYK stock is 2.81.
What is the 5Y average PEG ratio for Stryker Corporation (SYK)?
The 5Y average PEG ratio for SYK stock is 2.63.
What is the 10Y average PEG ratio for Stryker Corporation (SYK)?
The 10Y average PEG ratio for SYK stock is 1.79.
What is the 15Y average PEG ratio for Stryker Corporation (SYK)?
The 15Y average PEG ratio for SYK stock is 1.70.
What is the 20Y average PEG ratio for Stryker Corporation (SYK)?
The 20Y average PEG ratio for SYK stock is 1.19.

Stryker Corporation PEG Ratio History

DATEPEG RATIO
2025-12-315.16
2023-12-311.06
2022-12-312.21
2021-12-312.09
2018-12-310.07
2016-12-311.79
2015-12-310.13
2011-12-311.70
2010-12-311.11
2008-12-311.07
2007-12-311.01
2006-12-311.49
2005-12-310.58
2004-12-3145.31
2003-12-311.24
2002-12-311.99
2001-12-311.82
2000-12-310.04
1997-12-311.29
1996-12-311.59

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Portage, MI
53,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Kevin A. Lobo